PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.

Detalles Bibliográficos
Autores principales: Yassin, Mohamed, Elenga, Narcisse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429163/
http://dx.doi.org/10.1097/01.HS9.0000976816.43525.2d
_version_ 1785090642109530112
author Yassin, Mohamed
Elenga, Narcisse
author_facet Yassin, Mohamed
Elenga, Narcisse
author_sort Yassin, Mohamed
collection PubMed
description
format Online
Article
Text
id pubmed-10429163
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291632023-08-17 PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY. Yassin, Mohamed Elenga, Narcisse Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429163/ http://dx.doi.org/10.1097/01.HS9.0000976816.43525.2d Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Yassin, Mohamed
Elenga, Narcisse
PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title_full PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title_fullStr PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title_full_unstemmed PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title_short PB2529: RENAL FUNCTIONS EVOLUTION OF 6 SCD PATIENTS TREATED BY L-GLUTAMINE PHARMACEUTICAL GRADE FOR 30 MONTHS: A REAL-WORLD STUDY.
title_sort pb2529: renal functions evolution of 6 scd patients treated by l-glutamine pharmaceutical grade for 30 months: a real-world study.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429163/
http://dx.doi.org/10.1097/01.HS9.0000976816.43525.2d
work_keys_str_mv AT yassinmohamed pb2529renalfunctionsevolutionof6scdpatientstreatedbylglutaminepharmaceuticalgradefor30monthsarealworldstudy
AT elenganarcisse pb2529renalfunctionsevolutionof6scdpatientstreatedbylglutaminepharmaceuticalgradefor30monthsarealworldstudy

Ejemplares similares